Sulphoxybenzamides

A compound of formula I

• 9
• wherein
• Z0 denotes a group selected from the formulae —X1—(CH2)r—X2— and —CR4R5—,
• A1 and A2 independently of one another each denote a 1,4-phenylene- or 1,3-phenylene group, each optionally substituted by one or more halogen atoms, C1—C8-alkyl groups, C2—C8-alkenyl groups, C1—C8-haloalkyl groups or C1—C8-alkoxy groups,
• Z1 and Z2 independently of one another each denote a group of formula —X3—(CH2)s—X4— or a single bond,
• R1 denotes hydrogen, hydroxy, —COO—C1—C8-alkyl or —COO—C1—C4-alkyl-phenyl, wherein said phenyl group may be substituted by C1—C4-alkyl or C1—C4-alkoxy,
• R2 and R3 independently of one another each denote a hydrogen or halogen atom, or a C1—C8-alkyl, C1—C8-haloalkyl, C1—C8-alkoxy, aryl, aryloxy or aralkyl group,
• R4 and R5 independently of one another each denote hydrogen or C1—C4-alkyl,
• X1 and X2 independently of one another each denote —O, —S, —NH— or a single bond,
• X3 and X4 independently of one another each denote —O, —S, —NH— or a single bond,
• m and n independently of one another each denote 0 or 1, and
• r and s independently of one another denote an integer from 1 to 8,
• optionally in the form of a tautomer, racemate, enantiomer, diastereomer and mixtures thereof, or a pharmacologically acceptable salt thereof.